VENOARTERIAL ECMO AS BRIDGE TO HEART TRANSPLANTATION. A GOOD CHANCE by R Viejo Moreno et al.
POSTER PRESENTATION Open Access
Venoarterial ecmo as bridge to heart
transplantation. a good chance
R Viejo Moreno*, JL Pérez Vela, M Talayero Giménez de Azcárate, MA Corres Peiretti, E Renes Carreño,
T Grau Carmona, J Gutiérrez Rodríguez, JC Montejo González
From ESICM LIVES 2015
Berlin, Germany. 3-7 October 2015
Introduction
Veno-arterial extracorporeal membrane oxigenation
(VA-ECMO) is a increasingly device used in patients
with a refractory cardiogenic shock. The most important
decision before the implantation is to establish the best
moment and what is the objective on the basis of
INTERMACS criteria.
Objectives
To analyze our results in the management of refractory
cardiogenic shock (CS) which required venoarterial
extracorporeal membrane oxygenation (VA-ECMO) as
bridge to heart transplantation. Are these results similar
to the other transplanted patients without ECMO?
Methods
An observational prospective study was conducted from
March 2010 to February 2015. We reviewed the clinical
characteristics and evolution of patients who received
venoarterial ECMO as bridge to heart transplant. We ana-
lyzed demographic variables, underlying cause of CS, com-
plications and global survival. The quantitative variables
are presented as mean ± SD or as median and 25th -75th
percentile range and as percentage.
Results
We studied 17 patients. The mean age was 40 ± 13 years,
56% female. Most common underlying causes were idio-
pathic dilated cardiomyopathy (41.2%), ischemic dilated
cardiomyopathy (23.5%) and acute myocardial infarction
(11.7%). Before insertion, all patients were under inotropic
support and 75% had intra aortic balloon pump. Renal fail-
ure was in 31% of patients.
All device insertions were peripheral, 88% femorofe-
moral. The length of ECMO was 192 hours (129 - 317)
with a maximum of 480 hours. Only one patient pre-
sented several bleeding due to accidental decannulation
and other patient had a several vascular complication
(lower extremity ischemia). Nine patients (53%) had
renal failure and four of them developed multiple organ
failure. Fourteen of seventeen patients received a heart
transplant (82%). It was possible a successful weaning in
ten cases but two patients presented primary graft dys-
function and needed a second VA-ECMO. Both could
be weaned from ECMO. Global survival in our series
was 70.6%. Overall survival in the series analyzed was
around 80-85%.
Conclusions
VA-ECMO should be considered an effective therapeutic
support for patients with refractory CS because it enables
patients to reach to transplantation with favorable results.
These are slightly lower than the results reported in the
general series of heart transplant.
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